Search alternatives:
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
age increased » rate increased (Expand Search), use increased (Expand Search), large increases (Expand Search)
i largest » _ largest (Expand Search)
i large » _ large (Expand Search), a large (Expand Search), via large (Expand Search)
b large » _ large (Expand Search), a large (Expand Search), _ larger (Expand Search)
a age » _ age (Expand Search), g age (Expand Search), 9 age (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
age increased » rate increased (Expand Search), use increased (Expand Search), large increases (Expand Search)
i largest » _ largest (Expand Search)
i large » _ large (Expand Search), a large (Expand Search), via large (Expand Search)
b large » _ large (Expand Search), a large (Expand Search), _ larger (Expand Search)
a age » _ age (Expand Search), g age (Expand Search), 9 age (Expand Search)
-
101
Image_7_Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell Lymphoma.eps
Published 2021“…<p>Absolute count of circulating monocytes has been proposed as an independent prognostic factor in diffuse large B-cell lymphoma (DLBCL). However, monocyte nomenclature includes various subsets with pro-, anti-inflammatory, or suppressive functions, and their clinical relevance in DLBCL has been poorly explored. …”
-
102
Large benefits to youth-focused HIV treatment-as-prevention efforts in generalized heterosexual populations: An agent-based simulation model - Fig 2
Published 2019“…<p><b>Simulations showing the percent of the population that is HIV+ (panels a-c, red lines), HIV+ and receiving treatment (panels a-c, blue lines), and HIV+ and receiving treatment specifically due to being part of a target group (panels a-c, purple lines); incidence (panels d-f); and AIDS death rates (panels g-h) following our “CD4<500” (left-side), “random” (middle), and “under age 30” (right side) treatment-as-prevention (TasP) strategies.…”
-
103
-
104
-
105
Supplementary Material for: Dysregulated MDR1 by PRDM1/Blimp1 Is Involved in the Doxorubicin Resistance of Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma
Published 2021“…In OCI-Ly3/DOX cells, NF-κB activity and PRDM1 expression decreased with an increase in drug-resistant index, whereas <i>MDR1</i> expression increased with enhanced drug resistance. …”
-
106
-
107
Table1_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.docx
Published 2024“…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). However, the mechanisms by which CISD2 regulates the occurrence and development of DLBCL remain to be fully elucidated.…”
-
108
Image_1_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.jpeg
Published 2022“…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …”
-
109
Image1_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.JPEG
Published 2024“…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). However, the mechanisms by which CISD2 regulates the occurrence and development of DLBCL remain to be fully elucidated.…”
-
110
Image_1_The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphoma.jpeg
Published 2023“…Background<p>Gut microbiota characteristics in patients with diffuse large B-cell lymphoma (DLBCL) are reportedly different when compared with the healthy population and it remains unclear if the gut microbiota affects host immunity and clinical disease features. …”
-
111
K2 increases the sensitivity of <i>K</i>. <i>pneumoniae</i> to polymyxin B.
Published 2022Subjects: -
112
-
113
-
114
-
115
Supplementary Material for: Effects of White Matter Hyperintensities on 90-Day Functional Outcome after Large Vessel and Non-Large Vessel Stroke
Published 2020“…<b><i>Material and Methods:</i></b> We reviewed acute ischemic stroke patients admitted between 2009 and 2017 at a large healthcare system in the USA. …”
-
116
-
117
-
118
Image_1_Role of Radiation Therapy Differs Between Stages in Primary Bone Large B-Cell Lymphoma in Rituximab Era: A Population-Based Analysis.jpeg
Published 2020“…</p><p>Results: A total of 1,320 patients were identified, including 856 with early-stage (ES) and 464 with advanced-stage (AS). …”
-
119
-
120